Article
A network pharmacology analysis on drug-like compounds from Ganoderma lucidum for alleviation of Atherosclerosis
2021-02-26
Abstract excerpt
<h4>Background: </h4> Ganoderma lucidum (GL) is known as a potent alleviator against chronic inflammatory disease like atherosclerosis (AS), but its critical bioactive compounds and their mechanisms against AS have not been unveiled. This research aimed to identify the key compounds(s) and mechanism(s) of GL against AS through network pharmacology. <h4>Methods: </h4>: The compounds from GL were identified by gas c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 86d8043e-fbee-5d86-bf14-c28ff8b4cf63
- DOI
- 10.21203/rs.3.rs-236410/v1
